San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Qpex Biopharma is raising $41,075,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Michael Dudley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Qpex Biopharma

QPEX BIOPHARMA is developing a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. Qpex management has a record of deep expertise in the discovery, development, and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance.

To learn more about Qpex Biopharma, visit http://www.qpexbio.com/

Contact:
Michael Dudley, Chief Executive Officer
858-774-7361
https://www.linkedin.com/in/dr-michael-dudley-0248261/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved